Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

67 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q2 2025.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 51,603,071 shares of 153,881,229 outstanding shares and own 33.53% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (11,447,140 shares), TANG CAPITAL MANAGEMENT LLC (8,223,612 shares), RA CAPITAL MANAGEMENT, L.P. (7,541,000 shares), GOLDMAN SACHS GROUP INC (3,752,098 shares), VANGUARD GROUP INC (3,272,522 shares), Carlyle Group Inc. (2,948,718 shares), ACADIAN ASSET MANAGEMENT LLC (2,074,604 shares), Schonfeld Strategic Advisors LLC (1,880,095 shares), RENAISSANCE TECHNOLOGIES LLC (1,153,816 shares), and REGENERON PHARMACEUTICALS, INC. (968,183 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.